Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Retail vs Mail Order Drug Prescribing: Trends and Costs in the Workers' Compensation System - A Preliminary Study Using Pharmacy Benefit Management Data for Ankle Sprain Claims.

Created on 12 Aug 2026

Authors

Edward J Bernacki, Nicholas F Tsourmas, Marcos A Iglesias, Paul D Buffone, Nimisha Kalia, Nina Leung, Judith Green-McKenzie, Xuguang Grant Tao

Published in

Journal of occupational and environmental medicine. Aug 11, 2026. Epub Aug 11, 2026.

Abstract

This study examines trends and cost disparities between retail and mail order pharmaceutical dispensing within the workers' compensation system.
Pharmacy benefit management (PBM) data were obtained for ankle sprain claims filed with a nationwide workers' compensation carrier between 2012-2024.
During the study period, the ratio of mail order versus retail pharmacies scripts increased. Mail order prescriptions demonstrated higher cost ratios per unit (pill) than retail pharmacies for opioids (1.75), and a sleep agent (1.46), similar costs for analgesics (1.08), antiseizure (0.95), and nonsteroidal medications (0.94) but lower costs for muscle relaxants (0.84). Mail order pharmacies dispensed a longer duration supply per script.
Mail-order prescriptions consistently provided longer days' supply across all major drug classes, yet they sometime carried higher costs per unit-especially for opioids and sleep agents.

PMID:
42579836
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement